title: Treatment of depression in older adults beyond fluoxetine.
abstract: This review aimed to discuss the importance of the comprehensive treatment of depression among older adults in Brazil. The abuse of selective serotonin reuptake inhibitors, including fluoxetine hydrochloride, as antidepressants has been considered a serious public health problem, particularly among older adults. Despite the consensus on the need for a comprehensive treatment of depression in this population, Brazil is still unprepared. The interface between pharmacotherapy and psychotherapy is limited due to the lack of healthcare services, specialized professionals, and effective healthcare planning. Fluoxetine has been used among older adults as an all-purpose drug for the treatment of depressive disorders because of psychosocial adversities, lack of social support, and limited access to adequate healthcare services for the treatment of this disorder. Preparing health professionals is a sine qua non for the reversal of the age pyramid, but this is not happening yet.
authors.forename: Gabriela Arantes
authors.initials: GA
authors.lastname: Wagner
mesh_terms: D000368:Aged; D018687:Antidepressive Agents, Second-Generation / Q000009:adverse effects*; D001938:Brazil; D003131:Combined Modality Therapy; D003191:Comprehensive Health Care; D017281:Cost of Illness; D003866:Depressive Disorder / Q000523:psychology* / Q000628:therapy*; D005473:Fluoxetine / Q000009:adverse effects* / Q000191:economics; D006801:Humans; D011613:Psychotherapy
chemical_list: D018687:Antidepressive Agents, Second-Generation; D005473:Fluoxetine
references.citation: J Affect Disord. 2012 Feb;136(3):212-21
references.pmid: 21194754
references.citation: Rev Bras Enferm. 2010 Mar-Apr;63(2):279-84
references.pmid: 20521001
references.citation: Clin Pharmacol Ther. 2009 Jan;85(1):86-8
references.pmid: 19037203
references.citation: Cien Saude Colet. 2012 Aug;17(8):2003-9
references.pmid: 22899141
references.citation: J Am Geriatr Soc. 2003 Dec;51(12):1718-28
references.pmid: 14687349
references.citation: J Affect Disord. 2012 Dec 15;142(1-3):172-9
references.pmid: 22940498
references.citation: Expert Opin Drug Saf. 2004 Sep;3(5):485-93
references.pmid: 15335303
references.citation: Clin Ther. 2009 May;31(5):945-61
references.pmid: 19539096
references.citation: Rev Saude Publica. 2000 Apr;34(2):126-35
references.pmid: 10881147
references.citation: Lancet. 2005 Jun 4-10;365(9475):1961-70
references.pmid: 15936426
references.citation: Rev Saude Publica. 2014 Dec;48(6):857-65
references.pmid: 26039387